ATE361321T1 - Lineare cyclodextrincopolymere - Google Patents
Lineare cyclodextrincopolymereInfo
- Publication number
- ATE361321T1 ATE361321T1 AT99931889T AT99931889T ATE361321T1 AT E361321 T1 ATE361321 T1 AT E361321T1 AT 99931889 T AT99931889 T AT 99931889T AT 99931889 T AT99931889 T AT 99931889T AT E361321 T1 ATE361321 T1 AT E361321T1
- Authority
- AT
- Austria
- Prior art keywords
- moieties
- linker
- cyclodextrin monomer
- cyclodextrin
- copolymer
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 7
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 7
- 125000005647 linker group Chemical group 0.000 abstract 5
- 239000000178 monomer Substances 0.000 abstract 5
- 229920000642 polymer Polymers 0.000 abstract 3
- 229920001577 copolymer Polymers 0.000 abstract 2
- 238000007334 copolymerization reaction Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Polyamides (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9155098P | 1998-07-01 | 1998-07-01 | |
| US09/203,556 US6509323B1 (en) | 1998-07-01 | 1998-12-02 | Linear cyclodextrin copolymers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361321T1 true ATE361321T1 (de) | 2007-05-15 |
Family
ID=26784076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99931889T ATE361321T1 (de) | 1998-07-01 | 1999-06-25 | Lineare cyclodextrincopolymere |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6509323B1 (de) |
| EP (2) | EP1764112B1 (de) |
| JP (2) | JP4741729B2 (de) |
| KR (1) | KR100851315B1 (de) |
| CN (1) | CN100365024C (de) |
| AT (1) | ATE361321T1 (de) |
| AU (1) | AU763114C (de) |
| BR (1) | BR9911754B1 (de) |
| CA (1) | CA2336390C (de) |
| CY (1) | CY1106797T1 (de) |
| DE (1) | DE69935982T2 (de) |
| DK (2) | DK1764112T3 (de) |
| ES (2) | ES2285844T3 (de) |
| HU (1) | HU229473B1 (de) |
| IL (2) | IL140552A0 (de) |
| MX (1) | MXPA01000206A (de) |
| PT (1) | PT1093469E (de) |
| WO (1) | WO2000001734A1 (de) |
Families Citing this family (138)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091192B1 (en) * | 1998-07-01 | 2006-08-15 | California Institute Of Technology | Linear cyclodextrin copolymers |
| US6509323B1 (en) * | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| KR100848121B1 (ko) * | 1998-07-01 | 2008-07-24 | 캘리포니아 인스티튜트 오브 테크놀로지 | 선형 사이클로덱스트린 공중합체 |
| US7375096B1 (en) * | 1998-12-04 | 2008-05-20 | California Institute Of Technology | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| EP1133318B1 (de) * | 1998-12-04 | 2007-03-14 | California Institute of Technology | Supramolekulare komplexe enthaltende arzneimittel |
| US6740643B2 (en) * | 1999-01-21 | 2004-05-25 | Mirus Corporation | Compositions and methods for drug delivery using amphiphile binding molecules |
| KR100371720B1 (ko) * | 2000-07-03 | 2003-02-06 | 광주과학기술원 | 사이클로덱스트린 또는 이의 유도체와 이작용성 또는다작용성 히드록시 화합물의 축중합물, 및 이의 제조방법 |
| TWI321054B (en) * | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
| RU2288921C2 (ru) * | 2000-12-19 | 2006-12-10 | Калифорниа Инститьют оф Текнолоджи | Композиции, содержащие комплексы включения |
| EP1275404A1 (de) * | 2001-07-11 | 2003-01-15 | SCA Hygiene Products AB | Geruchtskontrolle für Hygieneprodukte |
| US20040063654A1 (en) * | 2001-11-02 | 2004-04-01 | Davis Mark E. | Methods and compositions for therapeutic use of RNA interference |
| US20030157030A1 (en) * | 2001-11-02 | 2003-08-21 | Insert Therapeutics, Inc. | Methods and compositions for therapeutic use of rna interference |
| US7141540B2 (en) * | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
| TW515107B (en) * | 2001-12-25 | 2002-12-21 | Solidlite Corp | Power-saving light-emitting diode lamp |
| JP2005518470A (ja) * | 2002-02-22 | 2005-06-23 | インサート セラピューティクス インコーポレイテッド | 炭水化物−修飾ポリマー組成物及びその使用法 |
| DE60335608D1 (de) * | 2002-02-27 | 2011-02-17 | Pharmain Corp | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
| US7635463B2 (en) | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| FR2842106B1 (fr) * | 2002-07-11 | 2006-07-14 | Centre Nat Rech Scient | Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques |
| CN1694728B (zh) * | 2002-09-06 | 2011-12-28 | 天蓝制药公司 | 用于传递治疗剂的以环糊精为基础的聚合物 |
| ES2377318T3 (es) * | 2002-09-06 | 2012-03-26 | Cerulean Pharma Inc. | Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos |
| KR20050051686A (ko) * | 2002-10-09 | 2005-06-01 | 인설트 테라페틱스, 인코퍼레이티드 | 사이클로덱스트린-기초한 재료, 조성물 및 이의 용도 |
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| PT1581236E (pt) * | 2002-10-29 | 2013-12-24 | Insmed Inc | Libertação prolongada de anti-infecciosos |
| SG129240A1 (en) * | 2003-01-23 | 2007-02-26 | Agency Science Tech & Res | Biodegradable copolymer and nucleic acid delivery system |
| CA2518475C (en) | 2003-03-07 | 2014-12-23 | Alnylam Pharmaceuticals, Inc. | Irna agents comprising asymmetrical modifications |
| US20070179100A1 (en) * | 2003-04-09 | 2007-08-02 | Muthiah Manoharan | Protected monomers |
| US7851615B2 (en) * | 2003-04-17 | 2010-12-14 | Alnylam Pharmaceuticals, Inc. | Lipophilic conjugated iRNA agents |
| ES2702942T3 (es) | 2003-04-17 | 2019-03-06 | Alnylam Pharmaceuticals Inc | Agentes de ARNi modificados |
| US7723509B2 (en) | 2003-04-17 | 2010-05-25 | Alnylam Pharmaceuticals | IRNA agents with biocleavable tethers |
| US8017762B2 (en) * | 2003-04-17 | 2011-09-13 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
| JP4991288B2 (ja) | 2003-04-17 | 2012-08-01 | アルナイラム ファーマシューティカルズ， インコーポレイテッド | 二本鎖ｉＲＮＡ剤、および二本鎖ｉＲＮＡ剤の対合の安定性を調節する方法。 |
| US8796436B2 (en) | 2003-04-17 | 2014-08-05 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
| WO2005004794A2 (en) | 2003-06-09 | 2005-01-20 | Alnylam Pharmaceuticals Inc. | Method of treating neurodegenerative disease |
| US8372966B2 (en) | 2003-12-19 | 2013-02-12 | University Of Cincinnati | Oligonucleotide decoys and methods of use |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| AU2004311478A1 (en) | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| CA2558771C (en) * | 2004-03-05 | 2013-01-08 | Benitec, Inc. | Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| WO2005088655A1 (en) * | 2004-03-12 | 2005-09-22 | The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | A magnetoresistive medium |
| WO2005112977A2 (en) * | 2004-04-23 | 2005-12-01 | Pharmain, Ltd. | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| EP1797252A1 (de) * | 2004-09-18 | 2007-06-20 | Mirae Green Construction Co., Ltd. | Gerät zur verhinderung von erdeintritt in einen auffangkanal |
| US20090023671A1 (en) * | 2005-01-06 | 2009-01-22 | Brashears Sarah J | Rnai Agents for Maintenance of Stem Cells |
| NZ560936A (en) | 2005-02-03 | 2010-04-30 | Benitec Inc | RNAI expression constructs |
| US8008468B2 (en) * | 2005-02-16 | 2011-08-30 | Benitec, Inc. | RNAi expression constructs with liver-specific enhancer/promoter |
| JP2008537551A (ja) | 2005-03-31 | 2008-09-18 | カランド ファーマシューティカルズ， インコーポレイテッド | リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用 |
| WO2006116756A1 (en) * | 2005-04-28 | 2006-11-02 | Benitec, Limited. | Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns |
| CN101346393B (zh) | 2005-11-02 | 2015-07-22 | 普洛体维生物治疗公司 | 修饰的siRNA分子及其应用 |
| EP3067047B1 (de) | 2005-12-08 | 2022-04-20 | Insmed Incorporated | Antiinfektive zusammensetzungen auf lipidbasis zur behandlung von lungeninfekten |
| KR101529318B1 (ko) | 2005-12-19 | 2015-06-16 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법 |
| AU2006327551A1 (en) * | 2005-12-19 | 2007-06-28 | Capsutech Ltd. | Cyclodextrin-containing polymers and uses thereof |
| US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070178049A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
| US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| JP2009526858A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | コルチコステロイド溶液を製造する方法 |
| US8501478B2 (en) | 2006-06-15 | 2013-08-06 | University Of Cincinnati | Trehalose click polymers for delivery of biologically active molecules |
| US20080176958A1 (en) * | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
| US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
| US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| US7960336B2 (en) * | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
| US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
| CN101970012A (zh) * | 2007-09-14 | 2011-02-09 | 日东电工株式会社 | 药物载体 |
| CN101809039B (zh) * | 2007-09-28 | 2012-08-29 | 那诺蒂克株式会社 | 叶酸修饰的环糊精化合物、其制备方法、靶向性药物传递系统用的药物传递剂、药物组合物及造影剂 |
| US8040246B2 (en) * | 2007-12-04 | 2011-10-18 | Avaya Inc. | Systems and methods for facilitating a first response mission at an incident scene |
| ES2535419T3 (es) | 2007-12-27 | 2015-05-11 | Protiva Biotherapeutics Inc. | Silenciamiento de expresión de quinasa tipo polo usando ARN interferente |
| US20090176892A1 (en) | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| AU2009232355A1 (en) | 2008-04-04 | 2009-10-08 | Calando Pharmaceuticals, Inc. | Compositions and use of EPAS1 inhibitors |
| EP2281041B1 (de) | 2008-04-15 | 2014-07-02 | Protiva Biotherapeutics Inc. | Abdämpfen der csn5 genexpression unter verwendung von interferierender rns |
| EP2321414B1 (de) * | 2008-07-25 | 2018-01-10 | Alnylam Pharmaceuticals, Inc. | Verbesserung der sirna-silencing-aktivität unter verwendung universeller basen oder fehlpaarungen im sense-strang |
| US8309530B2 (en) * | 2009-02-04 | 2012-11-13 | Washington State University | Compositions and methods for modulating ghrelin-mediated conditions |
| WO2010099466A2 (en) | 2009-02-26 | 2010-09-02 | The Regents Of The University Of California | A supramolecular approach for preparation of size controllable nanoparticles |
| CN102781237A (zh) | 2009-11-23 | 2012-11-14 | 天蓝制药公司 | 用于传递治疗剂的基于环糊精的聚合物 |
| US20110178287A1 (en) | 2010-01-19 | 2011-07-21 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| US20110300150A1 (en) | 2010-05-18 | 2011-12-08 | Scott Eliasof | Compositions and methods for treatment of autoimmune and other disease |
| CA2802994A1 (en) | 2010-06-17 | 2011-12-22 | The United States Of America As Represented By The Secretary, National I Nstitutes Of Health | Compositions and methods for treating inflammatory conditions |
| EP2933333B1 (de) | 2010-07-08 | 2018-02-21 | Bonac Corporation | Einsträngiges nukleinsäuremolekül zur genexpressionssteuerung |
| EP2639307B1 (de) | 2010-08-03 | 2015-03-04 | Bonac Corporation | Einsträngiges Nukleinsäuremolekül mit stickstoffhaltigem alizyklischem Gerüst |
| CN103328500B (zh) | 2010-08-04 | 2018-01-26 | 西兹尔生物技术有限公司 | 用于癌症的诊断和治疗的方法和化合物 |
| US10307372B2 (en) | 2010-09-10 | 2019-06-04 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
| EP2635273B1 (de) | 2010-11-01 | 2020-01-08 | MEI Pharma, Inc. | Isoflavonoidzusammensetzungen und verfahren zur krebsbehandlung |
| WO2012145632A1 (en) * | 2011-04-21 | 2012-10-26 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| AU2012340086A1 (en) | 2011-11-17 | 2014-05-29 | The Regents Of The University Of California | Therapeutic RNA switches compositions and methods of use |
| BR112014014262A2 (pt) | 2011-12-14 | 2017-06-13 | Univ Johns Hopkins | nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas. |
| US9035039B2 (en) | 2011-12-22 | 2015-05-19 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing SMAD4 |
| CN104039961A (zh) | 2012-01-07 | 2014-09-10 | 株式会社博纳克 | 具有氨基酸骨架的单链核酸分子 |
| EP2804632B1 (de) | 2012-01-19 | 2019-09-18 | The Johns Hopkins University | Nanopartikelformulierungen mit verbesserter mukosaler penetration |
| US20130196906A1 (en) * | 2012-01-31 | 2013-08-01 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| US9598503B2 (en) | 2012-04-18 | 2017-03-21 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| PL2852391T3 (pl) | 2012-05-21 | 2022-04-11 | Insmed Incorporated | Układy do leczenia infekcji płuc |
| US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| US10124066B2 (en) | 2012-11-29 | 2018-11-13 | Insmed Incorporated | Stabilized vancomycin formulations |
| US10568975B2 (en) | 2013-02-05 | 2020-02-25 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
| WO2015127368A1 (en) | 2014-02-23 | 2015-08-27 | The Johns Hopkins University | Hypotonic microbicidal formulations and methods of use |
| US10335500B2 (en) | 2014-05-12 | 2019-07-02 | The Johns Hopkins University | Highly stable biodegradable gene vector platforms for overcoming biological barriers |
| JP6763780B2 (ja) | 2014-05-12 | 2020-09-30 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 合成脳浸透遺伝子ベクターの操作 |
| LT3466432T (lt) | 2014-05-15 | 2020-12-28 | Insmed Incorporated | Būdai, skirti plaučių netuberkuliozinėms mikobakterinėms infekcijoms gydyti |
| EP3201338B1 (de) | 2014-10-02 | 2021-11-03 | Arbutus Biopharma Corporation | Zusammensetzungen und verfahren zur ausschaltung einer hepatitis-b-virus-genexpression |
| KR20240126072A (ko) | 2015-01-27 | 2024-08-20 | 더 존스 홉킨스 유니버시티 | 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제 |
| CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
| WO2016197132A1 (en) | 2015-06-04 | 2016-12-08 | Protiva Biotherapeutics Inc. | Treating hepatitis b virus infection using crispr |
| WO2017019891A2 (en) | 2015-07-29 | 2017-02-02 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing hepatitis b virus gene expression |
| WO2017079537A1 (en) | 2015-11-04 | 2017-05-11 | Duke University | Polycationic polymers for use in treating and detecting cancer |
| EP3405501B1 (de) * | 2016-01-21 | 2023-11-15 | Aten Porus Lifesciences | Polymere auf cyclodextrinbasis, verfahren, zusammensetzungen und anwendungen davon |
| JP2019508037A (ja) | 2016-02-16 | 2019-03-28 | イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ | 標的化遺伝子編集を増強するための組成物およびその使用方法 |
| EP3500294A4 (de) | 2016-08-22 | 2020-07-29 | Arbutus Biopharma Corporation | Anti-pd-1-antikörper oder fragmente davon zur behandlung von hepatitis b |
| EP3548028A4 (de) * | 2016-12-01 | 2020-11-25 | Ellipses Pharma Limited | Krebsbehandlung |
| US12447464B2 (en) | 2016-12-22 | 2025-10-21 | Duke University | Polycationic microfibers and methods of using the same |
| US12054571B2 (en) | 2017-03-02 | 2024-08-06 | Osaka University | Host-group-containing polymerizable monomer, polymer material, method for producing same, and clathrate compound and method for producing same |
| WO2018169960A1 (en) | 2017-03-17 | 2018-09-20 | The Johns Hopkins University | Nanoparticle formulations for enhanced drug delivery to the bladder |
| WO2018187493A1 (en) | 2017-04-04 | 2018-10-11 | Yale University | Compositions and methods for in utero delivery |
| US20210188895A1 (en) | 2017-10-13 | 2021-06-24 | Bonac Corporation | Single-stranded nucleic acid molecule, and production method therefor |
| US10765638B2 (en) | 2017-11-03 | 2020-09-08 | Yale University | Particle formulation with polycation complex |
| EP3773505B1 (de) | 2018-03-30 | 2026-04-29 | Insmed Incorporated | Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten |
| JP7449275B2 (ja) | 2018-05-02 | 2024-03-13 | インスメッド インコーポレイテッド | リポソーム薬物製剤の製造方法 |
| US20210189431A1 (en) | 2018-08-10 | 2021-06-24 | Yale University | Compositions and methods for embryonic gene editing in vitro |
| US12496279B2 (en) | 2019-04-11 | 2025-12-16 | The Johns Hopkins University | Nanoparticles for drug delivery to brain |
| CN110016194A (zh) * | 2019-04-16 | 2019-07-16 | 无锡纯宇环保制品有限公司 | 一种有利于水体净化的可降解塑料袋 |
| WO2020257779A1 (en) | 2019-06-21 | 2020-12-24 | Yale University | Hydroxymethyl-modified gamma-pna compositions and methods of use thereof |
| WO2020257776A1 (en) | 2019-06-21 | 2020-12-24 | Yale University | Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof |
| US12496357B2 (en) | 2019-07-31 | 2025-12-16 | Yale University | Compositions and methods for treating sickle cell disease |
| WO2021081043A1 (en) | 2019-10-22 | 2021-04-29 | The Johns Hopkins University | Mucus penetrating particle compositions and methods of use thereof enhancing immune response |
| EP4192509A1 (de) | 2020-08-05 | 2023-06-14 | Ellipses Pharma Ltd | Behandlung von krebs mit einem cyclodextrinhaltigen polymer-topoisomerase-inhibitor-konjugat und einem parp-inhibitor |
| WO2022079209A1 (en) | 2020-10-15 | 2022-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tg2 inhibitors for improving mucociliary clearance in respiratory diseases |
| CN115160454A (zh) * | 2021-04-01 | 2022-10-11 | 四川大学 | 一种基于聚-β-环糊精与金刚烷主客体作用的超分子多醛化合物及其制备方法 |
| US20240279687A1 (en) | 2021-06-07 | 2024-08-22 | Yale University | Peptide nucleic acids for spatiotemporal control of crispr-cas binding |
| US20250241999A1 (en) | 2021-10-15 | 2025-07-31 | Georgia State University Research Foundation, Inc. | Delivery of therapeutic recombinant uricase using nanoparticles |
| US20250297141A1 (en) * | 2022-05-17 | 2025-09-25 | Lintec Corporation | Adhesive composition, adhesive, adhesive sheet, display body, and repeated bending device |
| EP4701639A1 (de) | 2023-05-31 | 2026-03-04 | University of Tartu | Auf infizierte gewebe abzielende moleküle und verfahren zur verwendung davon |
| WO2025184504A1 (en) | 2024-02-28 | 2025-09-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thermo-sensitive anti-fungal hydrogel compositions and methods of use |
| WO2025264861A1 (en) | 2024-06-18 | 2025-12-26 | Yale University | Compositions of bi-functional alpha helical peptides and methods thereof for treating tdp-43 proteinopathies |
| WO2026006542A2 (en) | 2024-06-26 | 2026-01-02 | Yale University | Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome |
| WO2026085322A1 (en) | 2024-10-18 | 2026-04-23 | Aardvark Therapeutics Inc. | Isoflavonoid formulations and methods of use |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE32268E (en) * | 1973-03-01 | 1986-10-21 | Strategic Medical Research Corp. | Therapeutic composition and method of therapeutically treating warm blooded animals therewith |
| JPS58167613A (ja) * | 1982-03-26 | 1983-10-03 | Mitsubishi Petrochem Co Ltd | 水溶性シクロデキストリン含有重合体の製造法 |
| HU191101B (en) * | 1983-02-14 | 1987-01-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu | Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups |
| US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US5166320A (en) | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| JP2993967B2 (ja) * | 1987-06-17 | 1999-12-27 | インスティテュート・フォー・チャイルド・ヘルス・リサーチ | ダニアレルゲンのクローニング |
| US4774329A (en) | 1987-08-04 | 1988-09-27 | American Maize-Products Company | Controlled release agent for cetylpyridinium chloride |
| US4941996A (en) | 1987-10-19 | 1990-07-17 | Minnesota Mining And Manufacturing Company | Inclusion complexes providing second harmonic generation |
| HU203899B (en) * | 1988-05-03 | 1991-10-28 | Forte Fotokemiai Ipar | Process for producing gelatine-cyclodextreine polymeres |
| US4902788A (en) | 1988-09-29 | 1990-02-20 | Uop | Crosslinked cyclodextrins supported on porous refractory inorganic oxides |
| JPH03221505A (ja) | 1990-01-29 | 1991-09-30 | Toppan Printing Co Ltd | シクロデキストリンポリマーの合成方法及びシクロデキストリン膜の製造方法 |
| IT1241417B (it) | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
| DE4009825A1 (de) | 1990-03-27 | 1991-10-02 | Consortium Elektrochem Ind | Wasserunloesliche cyclodextrin-polymerisate und verfahren zu deren herstellung |
| JPH0425505A (ja) * | 1990-05-21 | 1992-01-29 | Toppan Printing Co Ltd | シクロデキストリンポリマー及びシクロデキストリン膜の製造方法 |
| FR2665169A1 (fr) | 1990-07-30 | 1992-01-31 | Rhone Poulenc Chimie | Composes d'inclusion de cyclodextrines enfermant des antioxydants phenoliques et leur utilisation dans les polymeres. |
| JPH04106101A (ja) * | 1990-08-27 | 1992-04-08 | Showa Denko Kk | シクロデキストリンポリマーおよびその製造方法 |
| JPH0586103A (ja) * | 1990-10-01 | 1993-04-06 | Toppan Printing Co Ltd | シクロデキストリンポリマー |
| US5208316A (en) | 1990-10-01 | 1993-05-04 | Toppan Printing Co., Ltd. | Cyclodextrin polymer and cyclodextrin membrane prepared using said polymer |
| KR927003647A (ko) * | 1990-11-30 | 1992-12-18 | 돕빵 인사쯔 가부시끼가이샤 | 시클로덱스트린유도체 및 시클로덱스트린 고정화 폴리머의 제조방법 |
| CA2116431A1 (en) | 1991-09-06 | 1993-03-18 | Gurcharn S. Sidhu | Composition and method for reducing cholesterol concentration |
| NZ244306A (en) | 1991-09-30 | 1995-07-26 | Boehringer Ingelheim Int | Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation |
| JP3221505B2 (ja) | 1992-02-06 | 2001-10-22 | 日本信号株式会社 | 移動体の運行管理装置 |
| IT1256134B (it) | 1992-09-09 | 1995-11-29 | Luigi Boltri | Sali lipofili contenenti isotopi neutron attivabili e composizioni che li contengono |
| AU683631B2 (en) | 1992-11-30 | 1997-11-20 | Biocure, Inc. | Polymerizable carbohydrate esters, polymers made from such esters and the use of such polymers |
| TW328535B (en) | 1993-07-02 | 1998-03-21 | Novartis Ag | Functional photoinitiators and their manufacture |
| TW307775B (en) | 1994-02-15 | 1997-06-11 | Novartis Erfind Verwalt Gmbh | Unsaturated carbohydrate derivatives, polymers thereof and their use |
| US5691316A (en) | 1994-06-01 | 1997-11-25 | Hybridon, Inc. | Cyclodextrin cellular delivery system for oligonucleotides |
| US5776842A (en) | 1994-06-23 | 1998-07-07 | Cellresin Technologies, Llc | Cellulosic web with a contaminant barrier or trap |
| JP3699141B2 (ja) | 1994-09-24 | 2005-09-28 | 伸彦 由井 | 超分子構造の生体内分解性医薬高分子集合体及びその調製方法 |
| US6630351B1 (en) | 1999-06-07 | 2003-10-07 | Mirus Corporation | Compositions and methods for drug delivery using pH sensitive molecules |
| JP3830198B2 (ja) | 1996-03-29 | 2006-10-04 | 東光薬品工業株式会社 | 超分子構造高分子集合体を用いた皮膚透過性インドメタシン外用剤 |
| US6048736A (en) | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| US6509323B1 (en) * | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| KR100848121B1 (ko) * | 1998-07-01 | 2008-07-24 | 캘리포니아 인스티튜트 오브 테크놀로지 | 선형 사이클로덱스트린 공중합체 |
| EP1133318B1 (de) * | 1998-12-04 | 2007-03-14 | California Institute of Technology | Supramolekulare komplexe enthaltende arzneimittel |
| US6740643B2 (en) | 1999-01-21 | 2004-05-25 | Mirus Corporation | Compositions and methods for drug delivery using amphiphile binding molecules |
| WO2000075162A1 (en) | 1999-06-07 | 2000-12-14 | Mirus Corporation | A compound containing a labile disulfide bond |
| EP1233671A4 (de) | 1999-11-29 | 2005-11-02 | Mirus Corp | Zusammensetzungen und verfahren zur arzneistoffabgabe unter verwendung von amphiphilen bindungsmolekülen |
-
1998
- 1998-12-02 US US09/203,556 patent/US6509323B1/en not_active Expired - Lifetime
-
1999
- 1999-06-25 BR BRPI9911754-1A patent/BR9911754B1/pt not_active IP Right Cessation
- 1999-06-25 JP JP2000558134A patent/JP4741729B2/ja not_active Expired - Lifetime
- 1999-06-25 CN CNB998083801A patent/CN100365024C/zh not_active Expired - Fee Related
- 1999-06-25 ES ES99931889T patent/ES2285844T3/es not_active Expired - Lifetime
- 1999-06-25 AU AU48305/99A patent/AU763114C/en not_active Expired
- 1999-06-25 IL IL14055299A patent/IL140552A0/xx active IP Right Grant
- 1999-06-25 ES ES06024721T patent/ES2403416T3/es not_active Expired - Lifetime
- 1999-06-25 EP EP06024721A patent/EP1764112B1/de not_active Expired - Lifetime
- 1999-06-25 CA CA2336390A patent/CA2336390C/en not_active Expired - Lifetime
- 1999-06-25 EP EP99931889A patent/EP1093469B1/de not_active Expired - Lifetime
- 1999-06-25 DE DE69935982T patent/DE69935982T2/de not_active Expired - Lifetime
- 1999-06-25 PT PT99931889T patent/PT1093469E/pt unknown
- 1999-06-25 WO PCT/US1999/014298 patent/WO2000001734A1/en not_active Ceased
- 1999-06-25 DK DK06024721.0T patent/DK1764112T3/da active
- 1999-06-25 DK DK99931889T patent/DK1093469T3/da active
- 1999-06-25 MX MXPA01000206A patent/MXPA01000206A/es unknown
- 1999-06-25 AT AT99931889T patent/ATE361321T1/de active
- 1999-06-25 KR KR1020017000019A patent/KR100851315B1/ko not_active Expired - Lifetime
- 1999-06-25 HU HU0105472A patent/HU229473B1/hu unknown
-
2000
- 2000-12-26 IL IL140552A patent/IL140552A/en not_active IP Right Cessation
-
2007
- 2007-06-25 CY CY20071100840T patent/CY1106797T1/el unknown
-
2010
- 2010-09-01 JP JP2010195783A patent/JP2011006695A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE361321T1 (de) | Lineare cyclodextrincopolymere | |
| BR0115834A (pt) | Polìmeros em forma de pente modificados cationicamente, na base de ácido acriloildimetiltaurìnico | |
| ATE335025T1 (de) | Pfropfpolymerisate mit stickstoffheterocyclen enthaltenden seitenketten | |
| BR0115839A (pt) | Polìmeros em forma de pente enxertados, na base de ácido acriloildimetiltaurìnico | |
| BR0214120A (pt) | Polìmeros de enxerto, processo para a preparação e uso dos mesmos | |
| DE60114599D1 (de) | Adehyde enthaltende polymere als nassfestmittel | |
| BR0115765A (pt) | Copolìmeros enxertados à base de ácido acriloildimetiltaurìnico | |
| MX9206247A (es) | Agentes de transferencia de cadena de mercaptano latentes de tiol y su empleo en la sintesis de polimeros. | |
| FR2833604B1 (fr) | Composition polymere thermoplastique comprenant un copolyamide hyperbranche, et articles realises a partir de cette composition | |
| BR0115763A (pt) | Polìmeros em forma de pente modificados por flúor à base de ácido acriloildimetiltaurìnico | |
| DE69709110D1 (de) | Polymerisation mit "living" kennzeichen | |
| WO2002044225A3 (de) | Siliziummodifizierte kammpolymere auf basis von acryloyldimethyltaurinsäure (2-acrylamido-2-methyl-1-propansulfonsäure) | |
| TW200631604A (en) | Ophthalmic compositions comprising polyether substituted polymers | |
| ATE358144T1 (de) | Klebstoffe auf der basis von alpha- olefinpolymeren | |
| AU2385001A (en) | Polymers, their preparation and uses | |
| FI894278A0 (fi) | Menetelmä diallyylidimetyyliammoniumkloridin ja akryyliamidin korkean molekyylipainon omaavien kopolymeerien valmistamiseksi liuoksessa | |
| ATE293799T1 (de) | Kontaktlinsenmaterial auf basis von polysiloxanseitenketten enthaltenden makromonomere | |
| ATE545668T1 (de) | Klebstoffe | |
| NO893630L (no) | Fremgangsmaate for fremstilling av en vannloeselig kopolymer | |
| ATE366755T1 (de) | Amorphe perfluorierte polymere | |
| TW200502281A (en) | Comb copolymers with defined side chains and process for their manufacture | |
| ES2045352T3 (es) | Destintado de papeles usados. | |
| WO2020198630A3 (en) | Water compatible cationic graft copolymers and ink compositions comprising same | |
| TR200201706T1 (tr) | Düşük molekül ağırlıklı yan zincirler ile olefin aşı kopolimerlerinin yapılması için radyasyon prosesi | |
| WO1997049718A3 (fr) | Conjugues d'un oligonucleotide/polymere conducteur electronique avec une molecule d'interet, et leurs utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1093469 Country of ref document: EP |